| 000 | 00767nam a2200229 a 4500 | ||
|---|---|---|---|
| 008 | 040609c20042004flua^^^^^b^^^^001^0^eng^^ | ||
| 020 | _a0849313805 | ||
| 035 | _aMX001001000018 | ||
| 040 |
_aDNLM/DLC _bspa _cDLC _dNLM _dUKM _dC#P _dUNAMX |
||
| 041 | _aENG | ||
| 050 | 0 | 0 |
_aRA1238 _bG334 2004 |
| 082 | 0 | 0 |
_a615/.704 _221 |
| 100 | 1 |
_aGad, Shayne C., _d1948- _eautor |
|
| 245 | 1 | 0 |
_aSafety pharmacology in pharmaceutical development and approval / _cShayne C. Gad |
| 264 | 1 |
_aBoca Raton, Florida : _bCRC Press, _cc2004 |
|
| 300 |
_a189 páginas : _bilustraciones |
||
| 336 |
_atexto _2rdacontent |
||
| 337 |
_asin medio _2rdamedia |
||
| 338 |
_avolumen _2rdacarrier |
||
| 650 | 0 |
_aMedicamentos _xToxicología |
|
| 650 | 0 |
_aMedicamentos _xMedidas de seguridad |
|
| 999 |
_c11279 _d11279 |
||